Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Lands Merck Consumer As Springboard to Lead Global OTC Industry

This article was originally published in The Tan Sheet

Executive Summary

The $14.2 billion deal is “a major milestone on our path toward global leadership” in OTC sales, says Bayer Chairman Marijn Dekkers. The acquisition focuses on expanding international sales of Merck products including the Claritin allergy, Coppertone sunscreen and MiraLax constipation lines.

Advertisement

Related Content

Coppertone, Dr. Scholl’s On The Block As Bayer Narrows Consumer Health Focus
Coppertone, Dr. Scholl’s On The Block As Bayer Narrows Consumer Health Focus
Coppertone, Dr. Scholl’s On The Block As Bayer Narrows Consumer Health Focus
Consumer Health Sector Holds Private Equity Investors' Attention
Consumer Health Sector Holds Private Equity Investors' Attention
Consumer Health Sector Holds Private Equity Investors' Attention
Change At Bayer Consumer Helm As Drive To Top Stalls
Dihon Acquisition Doubles Bayer’s Consumer Health Presence In China
“Likely” Merck Consumer Health Sale Could Bring $8 Billion – Analysts
Bayer Aims For Global OTC Lead With Bolt-On Acquisition Plans

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106888

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel